A randomised, double-blind, placebo-controlled, four-way crossover study to compare the pharmacodynamics and pharmacokinetics of GW685698X [fluticasone-furoate] and GW642444M when administered separately and in combination as a single dose from a novel dry powder device in healthy Japanese subjects.

Trial Profile

A randomised, double-blind, placebo-controlled, four-way crossover study to compare the pharmacodynamics and pharmacokinetics of GW685698X [fluticasone-furoate] and GW642444M when administered separately and in combination as a single dose from a novel dry powder device in healthy Japanese subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Nov 2016

At a glance

  • Drugs Vilanterol (Primary) ; Fluticasone furoate
  • Indications Asthma; Chronic obstructive pulmonary disease
  • Focus Pharmacodynamics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 18 Aug 2008 Actual study completion date is 1 May 2008 as reported by ClinicalTrials.gov.
    • 18 Aug 2008 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 28 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top